RT Journal
A1 Kuehn BM
T1 NEw aspirin recommendations
JF JAMA
JO JAMA
YR 2009
FD April 22
VO 301
IS 16
SP 1647
OP 1647
DO 10.1001/jama.2009.539
UL http://dx.doi.org/10.1001/jama.2009.539
AB 
The new recommendations update those issued in 2002 based on more recent data demonstrating that the risks and benefits of preventive aspirin therapy differ between men and women (http://www.ahrq.gov/clinic/uspstf/uspsasmi.htm). Accordingly, the task force now recommends aspirin use for men aged 45 to 79 years when the potential benefit of preventing myocardial infarction outweighs the potential harm of increased risk of gastrointestinal hemorrhage and for women aged 55 to 79 years when the potential benefit of reducing ischemic stroke outweighs the risk of increased gastrointestinal bleeding.